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Abstract
Background: The possible participation of endogenous islet catecholamines (CAs) in the control
of insulin secretion was tested.
Methods: Glucose-induced insulin secretion was measured in the presence of 3-Iodo-L-Tyrosine
(MIT), a specific inhibitor of tyrosine-hydroxylase activity, in fresh and precultured islets isolated
from normal rats. Incubated islets were also used to measure CAs release in the presence of low
and high glucose, and the effect of α2-(yohimbine [Y] and idazoxan [I]) and α1-adrenergic
antagonists (prazosin [P] and terazosin [T]) upon insulin secretion elicited by high glucose.
Results: Fresh islets incubated with 16.7 mM glucose released significantly more insulin in the
presence of 1 µM MIT (6.66 ± 0.39 vs 5.01 ± 0.43 ng/islet/h, p < 0.02), but did not affect significantly
the insulin response to low glucose. A similar enhancing effect of MIT upon insulin secretion was
obtained using precultured islets devoid of neural cells, but absolute values were lower than those
from fresh islets, suggesting that MIT inhibits islet rather than neural tyrosine hydroxylase. CAs
concentration in the incubation media of fresh isolated islets was significantly higher in the presence
of 16.7 than 3.3 mM glucose: dopamine 1.67 ± 0.13 vs 0.69 ± 0.13 pg/islet/h, p < 0.001, and
noradrenaline 1.25 ± 0.17 vs 0.49 ± 0.04 pg/islet/h, p < 0.02. Y and I enhanced the release of insulin
elicited by 16.7 mM glucose while P and T decreased such secretion.
Conclusion: Our results suggest that islet-originated CAs directly modulate insulin release in a
paracrine manner.
Background
Insulin secretion in response to glucose is modulated by
neural [1], hormonal and paracrine [2] factors that be-
stow great precision to the stimulus: secretion coupling
process. Catecholamines (CAs) contribute to this mecha-
nism by exerting a direct and dual effect on the B-cell to
induce either inhibition or stimulation of insulin secre-
tion through their interaction with α2 or α1 and β2 adren-
ergic receptors, respectively [3,4]. Since islet B-cells have
more α2 than α1 and β2 adrenergic receptors, physiolog-
ical concentrations of CAs will bind mainly to the α2 pop-
ulation receptors and thus inhibit insulin secretion [5–
8].
Although the effect of the sympathetic nervous system
(SNS) and of circulating CAs on islet physiology has been
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known about the possible participation of endogenously-
generated CAs in the control of islet function. Islet cells
have been shown to contain enzymes involved both in
the synthesis of CAs – tyrosine hydroxylase (TH) [9,10]
and dihydroxyphenylalanine (DOPA) decarboxylase
[11,12] – and in their inactivation – monoamine oxidase
[13,14].
We have recently measured TH activity in normal rat iso-
lated islets, showing an increase in the enzyme's activity,
and a decrease of CAs content and insulin release in rats
fed only with carbohydrates [15]. In these experiments,
comparable TH activity values were measured in islets
isolated from either control or solarectomized rats, thus
suggesting that the enzyme activity was of islet rather
than neural origin.
In order to gain evidence about the possible modulatory
role of CAs of endogenous islet origin as paracrine hor-
monal regulators of insulin secretion, we have currently
studied: a) The effect of 3-Iodo-L-Tyrosine (MIT) – a se-
lective drug usually used for the acute inhibition of TH in
neuroendocrine tissues [16] – on the insulin secretory
response of either fresh or precultured isolated islets to
glucose, and b) The effect of specific α2- or α1-adrenergic
receptor antagonists upon glucose-induced insulin se-
cretion in isolated islets, and c) The release of endog-
enous CAs by endocrine islet cells.
Methods
Chemicals and drugs
Collagenase was obtained from Serva Feinbiochemica,
(Heidelberg, Germany), while bovine serum albumin,
fraction V and other reagents of the purest available
grade were purchased from Sigma Chemical Co. (St. Lou-
is, USA).
Animals and islet isolation
Male Wistar rats (180–200 g) were used as a source of is-
lets. They were fed ad libitum and kept under conditions
of controlled temperature and lighting (12 h light and 12
h dark). After enzymatic digestion with collagenase, pan-
creases were repeatedly washed and the islets rapidly
hand-picked with siliconized glass pipettes under a dis-
secting microscope [17].
Islet culture
Isolated islets were cultured at 37°C in a humidified at-
mosphere for 24 h in plastic Petri dishes (NUNC) with
RPMI 1640 supplemented with Hepes (20 mM),
CO3HNa (4.1 mM), penicillin, streptomycin (100.000 U/
I and 100 mg/l, respectively), 10% newbom calf serum
[18], and 3 mM glucose. The pH was adjusted to 7.4. Af-
ter the first 24-h period, the culture medium was re-
placed by fresh medium with the same glucose
concentration; afterwards, the medium was changed
every second day until accomplishing the total one-week
culture period.
Islet incubation
Groups of 5 fresh or precultured isolated islets were in-
cubated for 30 min at 37°C in 600 µl Krebs-Ringer-bicar-
bonate buffer with 1% (w/v) bovine-serum albumin,
Trasylol™ (400 IU/ml), and either 3.3 or 16.7 mM glu-
cose, with or without MIT (1 µM) [19]. The medium had
been previously gassed with a mixture of 5% CO2:95% O2
(v/v) to adjust the pH to 7.4.
Separately, groups of 5 fresh isolated islets were incubat-
ed for 60 min in the presence of α2-(yohimbine [Y, 0.1
and 1 µM] or idazoxan [I, 1 µM]) and α1- (prazosin [P, 0.1
and 0.5 µM] or terazosin [T, 0.1 and 0.5 µM]) adrenergic
antagonists. In all cases, aliquots from the medium were
obtained at the end of the incubation period and kept fro-
zen until insulin determination by radioimmunoassay
[20].
CAs quantitation
Another group of islets was incubated for 30 min in the
presence of 3.3 and 16.7 mM glucose. Following that in-
cubation period, CAs were measured in the incubation
media after partial purification by batch alumina extrac-
tion, separated by reverse-phase high-pressure liquid
chromatography on a 4.6 X 250-mm Zorbax Rp C18 col-
umn (DuPont), and quantified amperometrically with a
triple-electrode system (ESA, Bedford, NA) by measur-
ing the current produced upon exposure of the column
effluent to first oxidizing and then reducing potentials in
series [21].
Data analysis
For the statistical evaluation of the data, we employed
both variance analysis and the paired Student t-test.
Results
The addition of 1 µM MIT to the incubation medium of
fresh isolated islets enhanced significantly the release of
insulin elicited by 16.7 mM glucose (Fig. 1, upper pannel;
p < 0.02). Such effect was not observed in the presence
of a low glucose concentration. Similarly, MIT enhanced
significantly the release of insulin elicited by high glu-
cose in precultured islets (Fig. 1, lower pannel; p < 0.05).
In this case, however, the absolute insulin concentration
values measured in the incubation media were lower
than those measured in the experiments performed with
fresh islets.
The assessment of CAs in the incubation media from
freshly isolated islets showed a glucose-induced increase
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vs 16.7 mM glucose): dopamine 0.69 ± 0.13 (n = 4) vs
1.67 ± 0.13 (n = 6) pg/islet/h; p < 0.001, and noradrena-
line 0.49 ± 0.04 (n = 3) vs 1.25 ± 0.17 (n = 3) pg/islet/h;
p < 0.02.
Addition of selective α2- and α1- CA receptor antagonists
to the medium significantly affected the insulin released
by islets incubated with glucose: α2-antagonists Y (0.1
and 1 µM) and I (1 µM) enhanced significantly the release
of insulin in response to 16.7 mM glucose (p <
0.05,0.001, and 0.001, respectively; Fig. 2, upper pan-
nel), while α1-antagonists P and T (0.1 and 0.5 µM) de-
creased it significantly (P, p < 0.02 and 0.005, and T, p <
0.001, 0.001, respectively; Fig. 2, lower pannel). Except-
ing I, the effect of the antagonists was dose-dependent:
insulin release increased 82, 171 and 895 % in the pres-
ence of 0.1 and 1 µM Y and 1 µM I, respectively, while it
decreased 40 and 49% with 0.1 and 0.5 µM P, and 51 and
45% in the presence of T at the same concentrations.
Discussion
In our experiments, MIT addition to the incubation me-
dium induced a significant increase in glucose-induced
insulin release, either from fresh or precultured isolated
islets. Incubation of different tissues with MIT, for even
shorter periods than the one we used, blocks significant-
ly the activity of TH, the first limiting step enzyme in CA
biosynthesis [16]. The presence of immunochemically
demonstrable TH in α and B islet cells has been reported
in fetal-mouse pancreases [9], and in the B-cells of sev-
eral adult rodents (Sprague Dawley rats, two strains of
mice, and pigmented guinea pigs) [10]. Further, we have
measured TH activity in the endocrine pancreas of nor-
mal adult rats, recording comparable TH activity values
in islets isolated from either control or solarectomized
rats (330 ± 40 vs 300 ± 80 pmol/mg protein/h), indicat-
ing that the TH activity measured was of islet rather than
neural origin [15]. We could then assume that as in other
tissues, TH inhibition by MIT decreases CA production
rate in the islets, and consequently its availability [22].
Following this reasoning, it could be argued that, at least
in our model, CAs synthesis (or availability) participates
in the regulation of insulin secretion.
Our cultured islets would be devoid of adrenergic inner-
vation since sympathetic neurons maintained in a cul-
ture medium with a Ca2+ concentration above 2 mM
(condition employed in our islet culture) do not survive
more than 6–8 days [23]. Since the blocking effect of
MIT was also observed using cultured islets, we can as-
sume that islet rather than neural CAs biosynthesis is in-
volved in this modulatory process of insulin secretion.
We cannot however completely exclude the possibility
that MIT could affect insulin secretion either directly or
by modifying other processes than CAs biosynthesis.
There is considerable evidence in the literature for the
possible presence of CAs biosynthesis in islet tissue: a)
We have recently reported the immunocytochemical
identification of DOPA decarboxylase in glucagon-con-
taining cells of normal adult rat islets [12]; b) Oomori et
al. have reported the presence of dopamine beta-hydrox-
ylase immunoreactivity in rat pancreatic cells which –
according to their features – were neither neural nor en-
docrine cells, and suggested that these cells may release
norepinephrine (NE) to adequate stimuli [24]; c) Lun-
dquist et al. detected dopamine in islets obtained from
chemically-sympathectomized mice by means of high-
performance liquid chromatography [25]; and d) Falck
and Hellman showed that B-cells from guinea-pig islets
Figure 1
Effect of MIT upon insulin secretion elicited by 16.7 mM glu-
cose in fresh (upper pannel) and precultured (lower pannel)
isolated islets of Langerhans. Each bar represents the mean ±
SEM and refers to 3 separate experiments and 12 individual
determinations. P values were <0.02 and <0.05 for fresh and
precultured islets, respectively.
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serve sympathetic nerves in the endocrine pancreas of
those animals.
CAs inhibit glucose-induced insulin secretion by inter-
acting with α2-adrenoceptors in B-cells, but could stim-
ulate insulin secretion by two differents actions:
activation of B-cell α1 and β2 adrenoceptors [28], and a
direct action on α-cells, mediated by α2 and β2 adreno-
ceptors, which stimulate glucagon secretion [29,30]. We
have currently observed that high glucose induced an in-
crease in the release of CAs from normal rat isolated is-
lets to the incubation media. We have also found that
different α2- and α1-adrenergic antagonists added to the
incubation media significantly enhanced and decreased,
respectively, the secretion of insulin elicited by glucose in
a dose-dependent manner. The adrenoceptor blockade
by Y increased the secretion of insulin by 82 and 172%
while I enhanced such secretion by 895%. Conversely, P
and T diminished insulin secretion by 40–49% and 51–
45%, respectively, with the doses currently employed. As
shown by other authors, the uneven effect of adrenergic
antagonists could be ascribed to the relative abundance
or activity of α2-adrenoceptors in B-cells, as compared
with α1- and β2-adrenoceptors [5–8]. On the other hand,
Schuit et al. showed that P was ineffective in both a and
B-cells [31]; such discrepancy with our results can be at-
tributed to the method used in each case.
Since we did not add CAs to the incubation media, it
could be assumed that the effect of the antagonists was
due to an interference with the action of CAs, elaborated
and co-released with insulin by endocrine islet cells. The
results presented here as well our previous report on the
glucose-induced release of CAs by isolated rat islets [32]
support this assumption. On account of these results,
therefore, we postulate that islet-originated CAs could
directly modulate the release of insulin in a paracrine
hormonal manner.
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